The α1b-adrenoceptor exists as a higher-order oligomer: Effective oligomerization is required for receptor maturation, surface delivery, and function

Molecular Pharmacology

Volumn 71, Issue 4, 2007, Pages 1015-1029

  Lopez Gimenez, Juan F ^a   Canals, Meritxell ^a   Pediani, John D ^a   Milligan, Graeme ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1B ADRENERGIC RECEPTOR; OLIGOMER; ADRENERGIC RECEPTOR ALPHA(1B); ALPHA 1 ADRENERGIC RECEPTOR; CELL SURFACE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE; CELL SURFACE; CHROMATOPHORE; CONTROLLED STUDY; FLUORESCENCE RESONANCE ENERGY TRANSFER; GLYCOSYLATION; HUMAN; HUMAN CELL; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; CELL LINE; CHEMISTRY; DIMERIZATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHYSIOLOGY; PROTEIN TRANSPORT; SITE DIRECTED MUTAGENESIS;

CELL LINE; CELL MEMBRANE; DIMERIZATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; GLYCOSYLATION; HUMANS; MUTAGENESIS, SITE-DIRECTED; PROTEIN TRANSPORT; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, CELL SURFACE; TRANSFECTION;

EID: 33947362780     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.106.033035     Document Type: Article

References (37)

1. Baneres JL and Parello J (2003) Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. J Mol Biol 329:815-829.
2. Bernier V, Bichet DG, and Bouvier M (2004) Pharmacological chaperone action on G-protein-coupled receptors. Curr Opin Pharmacol 4:528-533.
3. 1B-adrenergic receptor: effects on receptor expression and function. Biochemistry 41:4281-4291.
4. Bulenger S, Marullo S, and Bouvier M (2005) Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends Pharmacol Sci 26:131-137.
5. 1b-adrenoceptor. Mol Pharmacol 66:1123-1137.
6. Conn PM, Knollman PE, Brothers, and Janovick JA (2006) Protein folding as post-translational regulation: evolution of a mechanism for controlled plasma membrane expression of a GPCR. Mol Endocrinol 20:3035-3041.
7. de Juan D, Mellado M, Rodriguez-Frade JM, Hernanz-Falcon P, Serrano A, Del Sol A, Valencia A, Martinez-A C, and Rojas AM (2005) A framework for computational and experimental methods: Identifying dimerization residues in CCR chemokine receptors. Bioinformatics 21(Suppl 2):ii13-ii18.
8. Ding WQ, Cheng ZJ, McElhiney J, Kuntz SM, and Miller LJ (2002) Silencing of secretin receptor function by dimerization with a misspliced variant secretin receptor in ductal pancreatic adenocarcinoma. Cancer Res 62:5223-5229.
9. Duvernay MT, Filipeanu CM, and Wu G (2005) The regulatory mechanisms of export trafficking of G protein-coupled receptors. Cell Signal 17:1457-1465.
10. Erickson MG, Moon DL, and Yue DT (2003) DsRed as a potential FRET partner with CFP and GFP. Biophys J 85:599-611.
11. Fotiadis D, Liang Y, Filipek S, Saperstein DA, Engel A, and Palczewski K (2004) The G protein-coupled receptor rhodopsin in the native membrane. FEBS Lett 564:281-288.
12. Franco R, Casado V, Mallol J, Ferrada C, Ferre S, Fuxe K, Cortes A, Ciruela F, Lluis C, and Canela EI (2006) The two-state dimer receptor model: a general model for receptor dimers. Mol Pharmacol 69:1905-1912.
13. Galperin E, Verkhusha VV, and Sorkin A (2004) Three-chromophore FRET microscopy to analyse multiprotein interactions in living cells. Nat Methods 1:209-217.
14. Guo W, Shi JA, and Javitch JA (2003) The fourth transmembrane segment forms the interface of the dopamine D2 receptor homodimer. J Biol Chem 278:4385-4388.
15. Guo W, Shi L, Filizola M, Weinstein H, and Javitch JA (2005) Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation. Proc Natl Acad Sci USA 102:17495-17500.
16. Herman B, Krishnan RV, and Centonze VE (2004) Microscopic analysis of fluorescence resonance energy transfer (FRET). Methods Mol Biol 261:351-370.
17. Hernanz-Falcon P, Rodriguez-Frade JM, Serrano A, Juan D, del Sol A, Soriano SF, Roncal F, Gomez L, Valencia A, Martinez AC, et al. (2004) Identification of amino acid residues crucial for chemokine receptor dimerization. Nat Immunol 5:216-223.
18. Hu CD, Chinenov Y, and Kerpolla TK (2002) Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol Cell 9:789-798.
19. Kerppola TK (2006) Visualization of molecular interactions by fluorescence complementation. Nat Rev Mol Cell Biol 7:449-456.
20. Lee SP, O'Dowd BF, Rajaram RD, Nguyen T, and George SR (2003) D2 dopamine receptor homodimerization is mediated by multiple sites of interaction, including an intermolecular interaction involving transmembrane domain 4. Biochemistry 42:11023-11031.
21. Liang Y, Fotiadis D, Filipek S, Saperstein DA, Palczewski K, and Engel A (2003) Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J Biol Chem 278:21655-21662.
22. Mansoor SE, Palczewski K, and Farrens DL (2006) Rhodopsin self-associates in asolectin liposomes. Proc Natl Acad Sci USA 103:3060-3065.
23. Meyer BH, Segura J-M, Martinez KL, Hovius R, George N, Johnsson K, and Vogel H (2006) FRET imaging reveals that functional neurokinin-1 receptors are monomeric and reside in membrane microdomains of live cells. Proc Natl Acad Sci USA 103:2138-2143.
24. Milligan G (2004) G protein-coupled receptor dimerization: function and ligand pharmacology. Mol Pharmacol 66:1-7.
25. Milligan G (2006) G-protein-coupled receptor heterodimers: pharmacology, function and relevance to drug discovery. Drug Discov Today 11:541-549.
26. Milligan G and Bouvier M (2005) Methods to monitor the quaternary structure of G protein-coupled receptors. FEBS J 272:2914-2925.
27. Morris DP, Price RR, Smith MP, Lei B, and Schwinn DA (2004) Cellular trafficking of human α1a-adrenergic receptors is continuous and primarily agonist-independent. Mol Pharmacol 66:843-854.
28. Park PS, Filipek S, Wells JW, and Palczewski K (2004) Oligomerization of G protein-coupled receptors: past, present, and future. Biochemistry 43:15643-15656.
29. Park PS and Wells JW (2004) Oligomeric potential of the M2 muscarinic cholinergic receptor. J Neurochem 90:537-548.
30. 1a-adrenoceptor endocytosis causes intracellular transportation of α-blockers via recycling compartments. Mol Pharmacol 67:992-1004.
31. Petaja-Repo UE, Hogue M, Laperriere A, Walker P, and Bouvier M (2002) Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human delta opioid receptor. J Biol Chem 275:13727-13736.
32. Pfleger KD and Edine KA (2006) Illuminating insights into protein-protein interactions using bioluminescence resonance energy transfer (BRET). Nat Methods 3:165-174.
33. Pietila EM, Tuusa JT, Apaja PM, Aatsinki JT, Hakalahti AE, Rajaniemi HJ, and Petaja-Repo UE (2005) Inefficient maturation of the rat luteinizing hormone receptor. A putative way to regulate receptor numbers at the cell surface. J Biol Chem 280:26622-26629.
34. Salahpour A, Angers S, Mercier JF, Lagace M, Marullo S, and Bouvier M (2004) Homodimerization of the β2-adrenergic receptor as a prerequisite for cell surface targeting. J Biol Chem 279:33390-33397.
35. Strange PG (2005) Oligomers of D2 dopamine receptors: evidence from ligand binding. J Mol Neurosci 26:155-160.
36. Ulloa-Aguirre A, Janovick JA, Brothers SP, and Conn PM (2004) Pharmacologic rescue of conformationally defective proteins: implications for the treatment of human disease. Traffic 5:821-837.
37. Wilson S, Wilkinson G, and Milligan G (2005) The CXCR1 and CXCR2 receptors form constitutive homo- and heterodimers selectively and with equal apparent affinities. J Biol Chem 280:28663-28674.